
Robert H. Havlin
Examiner (ID: 13636, Phone: (571)272-9066 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1639, 1692, 1626, 1609, 1622, 1675 |
| Total Applications | 1474 |
| Issued Applications | 736 |
| Pending Applications | 143 |
| Abandoned Applications | 608 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19246766
[patent_doc_number] => 20240197750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => CEFTIBUTEN DOSING REGIMENS
[patent_app_type] => utility
[patent_app_number] => 18/553769
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553769
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553769 | CEFTIBUTEN DOSING REGIMENS | Mar 30, 2022 | Pending |
Array
(
[id] => 18085482
[patent_doc_number] => 11535599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Benzisoxazole derivative
[patent_app_type] => utility
[patent_app_number] => 17/701539
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 34752
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701539
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701539 | Benzisoxazole derivative | Mar 21, 2022 | Issued |
Array
(
[id] => 18631543
[patent_doc_number] => 20230290446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => FEATURIZATION OF CARBON DIOXIDE CAPTURE CHARACTERISTICS IN MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/653897
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653897 | FEATURIZATION OF CARBON DIOXIDE CAPTURE CHARACTERISTICS IN MOLECULES | Mar 7, 2022 | Pending |
Array
(
[id] => 19232108
[patent_doc_number] => 20240189299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => ORAL FILM OF CFTR MODULATOR(S)
[patent_app_type] => utility
[patent_app_number] => 18/549234
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549234
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549234 | ORAL FILM OF CFTR MODULATOR(S) | Mar 7, 2022 | Pending |
Array
(
[id] => 19172433
[patent_doc_number] => 20240158407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHOD FOR PREPARATION OF AMIDINES
[patent_app_type] => utility
[patent_app_number] => 18/549406
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549406
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/549406 | METHOD FOR PREPARATION OF AMIDINES | Mar 2, 2022 | Pending |
Array
(
[id] => 19386995
[patent_doc_number] => 20240276865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => ORGANOMETALLIC IRIDIUM COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/562194
[patent_app_country] => US
[patent_app_date] => 2022-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 446
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562194
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562194 | ORGANOMETALLIC IRIDIUM COMPOUND AND APPLICATION THEREOF | Feb 25, 2022 | Pending |
Array
(
[id] => 19432421
[patent_doc_number] => 20240300919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => A PROCESS FOR PREPARING BATEFENTEROL AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/277340
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277340
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/277340 | A PROCESS FOR PREPARING BATEFENTEROL AND INTERMEDIATES THEREOF | Feb 17, 2022 | Pending |
Array
(
[id] => 19265309
[patent_doc_number] => 20240209008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/279422
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279422 | METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND | Feb 3, 2022 | Pending |
Array
(
[id] => 18093445
[patent_doc_number] => 20220411786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING
[patent_app_type] => utility
[patent_app_number] => 17/591930
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591930
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/591930 | REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING | Feb 2, 2022 | Pending |
Array
(
[id] => 19065575
[patent_doc_number] => 20240100001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => DENATONIUM SALT FOR USE IN PREVENTING, PREVENTING PROGRESSION AND TREATING FATTY LIVER DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/274180
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274180
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274180 | DENATONIUM SALT FOR USE IN PREVENTING, PREVENTING PROGRESSION AND TREATING FATTY LIVER DISEASES | Jan 30, 2022 | Pending |
Array
(
[id] => 19448885
[patent_doc_number] => 20240309015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Methods for the Treatment of Fibrotic Disease
[patent_app_type] => utility
[patent_app_number] => 18/273646
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -214
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273646 | Methods for the Treatment of Fibrotic Disease | Jan 26, 2022 | Pending |
Array
(
[id] => 19050784
[patent_doc_number] => 20240092753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => PROCESS FOR PRODUCTION OF INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 18/261182
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261182 | PROCESS FOR PRODUCTION OF INTERMEDIATES | Jan 13, 2022 | Pending |
Array
(
[id] => 17734600
[patent_doc_number] => 20220220059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => PROCESS FOR CRYSTALLIZATION OF HIGH PURITY LUTEIN ESTERS FROM MARIGOLD EXTRACTS
[patent_app_type] => utility
[patent_app_number] => 17/575227
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575227 | PROCESS FOR CRYSTALLIZATION OF HIGH PURITY LUTEIN ESTERS FROM MARIGOLD EXTRACTS | Jan 12, 2022 | Abandoned |
Array
(
[id] => 19018829
[patent_doc_number] => 20240075000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => TREATMENT OF PATHOLOGICAL FATIGUE WITH OXALOACETATE
[patent_app_type] => utility
[patent_app_number] => 18/272063
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272063
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272063 | TREATMENT OF PATHOLOGICAL FATIGUE WITH OXALOACETATE | Jan 12, 2022 | Pending |
Array
(
[id] => 19432413
[patent_doc_number] => 20240300911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => PURIFICATION METHOD FOR CITALOPRAM OR S-CITALOPRAM
[patent_app_type] => utility
[patent_app_number] => 18/261480
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261480
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/261480 | PURIFICATION METHOD FOR CITALOPRAM OR S-CITALOPRAM | Jan 9, 2022 | Pending |
Array
(
[id] => 19448848
[patent_doc_number] => 20240308978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/271192
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 699
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271192
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271192 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Jan 6, 2022 | Abandoned |
Array
(
[id] => 17656933
[patent_doc_number] => 20220177398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => Industrial Process for Manufacturing of Perfluoro (Methyl Vinyl Ether)(PFMVE) and of 2-Fluoro-1,2-Dichloro-Trifluoromethoxyethylene (FCTFE)
[patent_app_type] => utility
[patent_app_number] => 17/565492
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/565492 | Industrial Process for Manufacturing of Perfluoro (Methyl Vinyl Ether)(PFMVE) and of 2-Fluoro-1,2-Dichloro-Trifluoromethoxyethylene (FCTFE) | Dec 29, 2021 | Abandoned |
Array
(
[id] => 19464017
[patent_doc_number] => 20240317686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/270664
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270664
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270664 | RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Dec 28, 2021 | Abandoned |
Array
(
[id] => 19034057
[patent_doc_number] => 20240083872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/269692
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 595
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269692
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269692 | Cyclic amine derivatives having serotonin receptor binding activity | Dec 26, 2021 | Issued |
Array
(
[id] => 18987719
[patent_doc_number] => 20240059688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/258873
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258873
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258873 | CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER | Dec 21, 2021 | Pending |